Problems of overdiagnosis and overprescribing in ADHD: Are they legitimate?

Psychiatric Times

Volumn 28, Issue 8, 2011, Pages 14-18

  Connor, Daniel F ^a  

^a UNIVERSITY OF CONNECTICUT SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 80052063477     PISSN: 08932905     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Goldman L, Genel M, Bezman R, Slanetz PJ. Diagnosis and treatment of attention-deficit/hyperactivity disorder in children and adolescents. Council on Scientific Affairs, American Medical Association. JAMA. 1998;279:1100-1107. (Pubitemid 28177819)
2. LeFever GB, Arcona AP, Antonuccio DO. ADHD among American schoolchildren: evidence of overdiagnosis and overuse of medication. Sci Rev Merit Health Pract. 2003;2:49-60.
3. Safer DJ, Malever M. Stimulant treatment in Maryland public schools. Pediatrics. 20O0;106:533-539. (Pubitemid 30664140)
4. Safer DJ, Zito JM, Fine EM. Increased methylphe-nidate usage for attention deficit disorder in the 1990s. Pediatrics. 1996;98(6, pt 1):1084-1088. (Pubitemid 26399270)
5. Visser SN, Lesesne CA, Perou R. National estimates and factors associated with medication treatment for childhood attention-deficit/hyperactivity disorder, Pediatrics. 2007;119(suppl1):S99-S106. (Pubitemid 46397953)
6. Mayes R, Bagwell C, Erkulwater J. ADHD and the rise in stimulant use among children. Harvard Rev Psychiatry. 2008;16:151-166. (Pubitemid 351883195)
7. Barkley RA. Attention-Deficit Hyperactivity Disorder: A Handbook for Diagnosis and Treatment. 3rd ed. New York: Guilford Press; 2006.
8. Solanto MV. Neuropsychopharmacological mechanisms of stimulant drug action in attention-deficit hyperactivity disorder: a review and integration. Behav Brain Res. 1998;94:127-152. (Pubitemid 28352470)
9. Castle L, Aubert RE, Verbrugge RR, et al. Trends in medication treatment for ADHD. J Atten Disord. 2007;10:335-342.
10. Olfson M, Marcus SC, Weissman MM, Jensen PS. National trends in the use of psychotropic medications by children. J Am Acad Child Adolesc Psychiatry. 2002;41:514-521. (Pubitemid 38338129)
11. Vitiello B, Zuvekas SH, Norquist GS. National estimates of antidepressant medication use among U.S. children, 1997-2002. J Am Acad Child Adolesc Psychiatry. 2006;45:271-279.
12. Drug Enforcement Administration, US Department of Justice. Controlled Substances: Proposed Aggregate Production Quotas for 2008. http://www. deadiversion.usdoj.gov/fed-regs/quotas/2008/fr1107.htm. Accessed July 7,2011.
13. Merikangas KR, He JP, Brody D, et al. Prevalence and treatment of mental disorders among US children in the 2001-2004 NHANES. Pediatrics. 2010; 125:75-81.
14. Centers for Disease Control and Prevention. Mental health In the United States. Prevalence of diagnosis and medication treatment for attention-deficit/hyperactivity disorder-2003. MMWR. 2005;54:842-847.
15. Angold A, Erkanli A, Egger HL, Costello EJ. Stimulant treatment for children: a community perspective. J Am Acad Child Adolesc Psychiatry. 2000;39: 975-984. (Pubitemid 30639785)
16. Kollins SH. Abuse liability of medications used to treat attention-deficit/hyperactivrty disorder (ADHD). Am J Addict. 2007;16(suppl 1 ):35-42; quiz 43-44.
17. Wilens TE, Adler LA, Adams J, et al. Misuse and diversion of stimulants prescribed for ADHD: a systematic review of the literature. J Am Acad Child Adolesc Psychiatry. 2008;47:21-31.
18. Kollins SH. A qualitative review of issues arising in the use of psycho-stimulant medications in patients with ADHD and co-morbid substance use disorders. Curr Med Res Opin. 2008;24:1345-1357. (Pubitemid 351741566)
19. Biederman J, Monuteaux MC, Mick E, et al. Young adult outcome of attention deficit hyperactivity disorder: a controlled 10-year follow-up study. Psychol Med 2006;36:167-179. (Pubitemid 43126141)
20. Pappadopulos E, Jensen PS, Chait AR, et al. Medication adherence in the MTA: saliva methylphe-nidate samples versus parent report and mediating effect of concomitant behavioral treatment. J Am Acad Child Adolesc Psychiatry. 2009;48:501-510.
21. Volkow ND, Ding YS, Fowler JS, et al. Is methyl-phenidate like cocaine? Studies on their pharmacokinetics and distribution in the human brain. Arch Gen Psychiatry. 1995;52:456-463.
22. Kollins SH. ADHD, substance use disorders, and psychostimulant treatment: current literature and treatment guidelines. J Atten Disord. 2008;12:115-125.
23. Dulcan M. Practice parameters for the assessment and treatment of children, adolescents, and adults with of attention-deficit/hyperactivity disorder. American Academy of Child Adolescent Psychiatry. J Am Acad Child Adolesc Psychiatry. 1997;36(10 suppl):85S-121S. (Pubitemid 27435161)
24. King RA. Practice parameters for the psychiatric assessment of children and adolescents. American Academy of Child Adolescent Psychiatry. J Am Acad Child Adolesc Psychiatry. 1997;36(10 suppl):4S-20S.
25. Bridges J, Fitzgerald L, Meyer J. New workforce roles in health care: exploring the longer-term Journey of organisational innovations. J Health Organ Manag. 2007;21:381-392.
26. Sciutto MJ, Eisenberg M. Evaluating the evidence for and against the overdiagnosis of ADHD. J Atten Disord. 2007;11:106-113.
27. Conners CK, March JS, Francis A, et al. Treatment of attention-deficit/ hyperactivity disorder: expert consensus guidelines. J Atten Disord. 2001;4(suppl 1):S1-S128.